Q98416228
report in the Riksdag 1992-11-17
Press Enter · cited answer in seconds
0 sources
Q98416228
Summary
Q98416228 is a report[1].
Key Facts
- Q98416228's instance of is recorded as report[2].
- Q98416228's part of the series is recorded as reports of the 1992/93 legislative session of the Riksdag[3].
- Q98416228's language of work or name is recorded as Swedish[4].
- Q98416228's publication date is recorded as +1992-11-17T00:00:00Z[5].
- Q98416228's main subject is recorded as medication[6].
- Q98416228's work available at URL is recorded as http://data.riksdagen.se/dokument/GG01SoU6[7].
- Q98416228's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GG01SoU6[8].
- Q98416228's applies to jurisdiction is recorded as Sweden[9].
- Q98416228's legal citation of this text is recorded as bet. 1992/93:SoU6[10].
- Q98416228's title is recorded as Följdlagstiftning med anledning av den nya läkemedelslagstiftningen m.m.[11].
- Q98416228's has immediate cause is recorded as Q98144046[12].
- Q98416228's maintained by WikiProject is recorded as Project Riksdagen's documents[13].
- Q98416228's copyright status is recorded as public domain[14].
- Q98416228's legislative committee is recorded as Committee on Health and Welfare[15].
- Q98416228's Swedish Riksdag document ID is recorded as GG01SoU6[16].